Doing Pharmaceutical business in Belarus 2021
Pharmaceutical markets of various countries around the globe have peculiar patterns of legal regulation, and Belarus is no exception. Many pharmaceutical guides of various countries tend to either contain the most general information, or, on the contrary, to set forth an entire text of all legislation.
This guide aims at more than depicting a specific regulation pattern applied to the Belarusian pharmaceutical market, its goal is to help you to independently assess risks and to form a competent and impartial judgement about the business opportunities in Belarus. This guide offers a comprehensive presentation of norms that regulate the pharmaceutical market in Belarus.
We believe that this guide will be most useful for pharmaceutical companies that treat Belarus as their prospective market, either for the production or for the sales of medicines.
This guide contains characteristics of regulations applied to all areas of pharmaceutical business, from registration and imports to price formation for medicines. We believe that this Doing Pharmaceutical Business in Belarus guide will answer your questions and will be a good assistant in making your business decisions.
The REVERA team is involved in the implementation of global pharmaceutical and healthcare projects, including those related to the protection of international pharmaceutical companies within their restructuring.
Get the overview file